000 | a | ||
---|---|---|---|
999 |
_c11053 _d11053 |
||
003 | OSt | ||
005 | 20200124111558.0 | ||
008 | 200124b xxu||||| |||| 00| 0 eng d | ||
040 |
_aAIKTC-KRRC _cAIKTC-KRRC |
||
100 |
_911920 _aHarika, V. |
||
245 |
_aCarbamazepine‑induced hyperglycemia _b: A rare case report |
||
250 | _aVol.51(5), Sep-Oct | ||
260 |
_aMumbai _bWolter Kluwer _c2019 |
||
300 | _a352-353p. | ||
520 | _aCarbamazepine is a commonly used iminostilbene antiepileptic medication and it is estimated that 46.9% of the total antiepileptic drug overdose in the United Kingdom is because of this drug. The overdose of Carbamazepine can show negative effects on multiple systems, these include neurologic (ataxia, seizures, and altered sensorium), cardiac (tachycardia, hypotension) and metabolic manifestations. We reported a case of a 17-year-old girl had an increase in glucose levels after voluntary ingestion carbamazepine tablets. After ingestion, her gross random blood sugar level was increased, then physician suspected that she might be a Type I diabetic,but HbA1C[glycosylated hemoglobin] levels was found normal.Carbamazepine was discontinued and patient received symptomatic therapy. The patient had decreased levels of blood sugar level,after removal of the drug within the next day after ingestion of carbamazepine. A Naranjo assessment was obtained, indicating a definite relationship between the patient’s increased in blood glucose levels and her use of carbamazepine | ||
650 | 0 |
_94774 _aPHARMACOLOGY |
|
700 |
_911921 _aParveen, S. |
||
773 | 0 |
_tIndian Journal of Pharmacology _dAndheri - Mumbai Wolters Kluwer India Private Limited _x0253-7613 |
|
856 |
_uhttp://www.ijp-online.com/temp/IndianJPharmacol515352-2032898_053848.pdf _yClick here |
||
942 |
_2ddc _cAR |